SOCORRO GENERAL HOSPITAL

CCN 321301

45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
Machine-readable file published
Gross / standard charges
Discounted cash price
Payer-specific negotiated rates
Min / max negotiated charges
Free, public, no login required
Procedures listed
14,184
Insurances with rates
3
CPT / HCPCS codes
11,290
Source MRF

Most expensive procedures (gross)

41096
$86,272
PACLITAXEL-PROTEIN BOUND 100 MG IV SOLR
Gross
$123,245
48729
$60,900
NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML IVES SUSP
Gross
$87,000
25339
$59,565
EMICIZUMAB-KXWH 150 MG/ML SUBQ SOLN
Gross
$85,093
48105
$59,230
GLOFITAMAB-GXBM 1 MG/ML IV SOLN (>10 MG DOSE 10 ML MIXTURE COMPONENT)
Gross
$84,614
49698
$51,028
DATOPOTAMAB DERUXTECAN-DLNK 100 MG IV SOLR
Gross
$72,897
47433
$39,686
NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20 ML IV SOLN
Gross
$56,694
49119
$38,272
IMETELSTAT 188 MG IV SOLR
Gross
$54,674
49107
$34,529
LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR
Gross
$49,327
34032
$31,065
YTTRIUM-90 (Y-90 THERASPHERE) GLASS MICROSPHERES
Gross
$44,379
48723
$28,980
TARLATAMAB-DLLE 10 MG IV SOLR
Gross
$41,400
49118
$28,967
TARLATAMAB-DLLE 10 MG IV SOLR
Gross
$41,381
31590
$25,631
LURBINECTEDIN 4 MG IV SOLR
Gross
$36,615
48264
$25,214
ELRANATAMAB-BCMM 40 MG/ML SUBQ SOLN
Gross
$36,020
31766
$24,868
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) IV SOLN
Gross
$35,526
44221
$24,550
PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 1,200 MG-600MG- 30000 UNIT/15ML SUBQ SOLN
Gross
$35,072
35787
$23,059
AMIVANTAMAB-VMJW 50 MG/ML IV SOLN
Gross
$32,941
46784
$21,473
DOSTARLIMAB-GXLY 50 MG/ML IV SOLN
Gross
$30,675
33152
$20,447
TESTOSTERONE 75 MG IMPL PLLT
Gross
$29,210
22762
$20,371
IPILIMUMAB 50 MG/10 ML (5 MG/ML) IV SOLN
Gross
$29,102
46427
$18,837
TREMELIMUMAB-ACTL 20 MG/ML IV SOLN
Gross
$26,910
39886
$18,111
SACITUZUMAB GOVITECAN-HZIY 180 MG IV SOLR
Gross
$25,873
49225
$17,955
TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) IV SOLN
Gross
$25,650
38133
$17,844
CEMIPLIMAB-RWLC 50 MG/ML IV SOLN
Gross
$25,491
8925
$17,441
TECLISTAMAB-CQYV 90 MG/ML SUBQ SOLN
Gross
$24,915
36564
$16,954
LUSPATERCEPT-AAMT 75 MG SUBQ SOLR
Gross
$24,220
41099
$16,927
PEMBROLIZUMAB 100 MG/4 ML (25 MG/ML) IV SOLN
Gross
$24,182
49775
$16,154
TISLELIZUMAB-JSGR 10 MG/ML IV SOLN
Gross
$23,077
36561
$15,082
FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG IV SOLR
Gross
$21,546
45000385
$14,654
HC OPEN TX TRIMALLEOLAR ANKLE FX INCL INT FIXATION MEDIAL/ LATERAL MALLEOLUS W/O FIXATION POST LIP
Gross
$20,934
31562
$14,633
DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBQ SOLN
Gross
$20,904
25073
$13,443
DURVALUMAB 50 MG/ML IV SOLN
Gross
$19,204
43293
$13,334
PANITUMUMAB 400 MG/20 ML (20 MG/ML) IV SOLN
Gross
$19,049
38791
$13,104
TRASTUZUMAB-QYYP 420 MG IV SOLR
Gross
$18,720
11021
$12,524
RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML IM SOLN
Gross
$17,892
44455
$12,520
TRABECTEDIN 1 MG IV SOLR
Gross
$17,885
35727
$12,400
PEGFILGRASTIM (NEULASTA) 6 MG/0.6ML SUBQ SYRG
Gross
$17,714
33962
$12,291
ROMIPLOSTIM 500 MCG SUBQ SOLR
Gross
$17,559
11439
$12,044
TRASTUZUMAB 150 MG IV SOLR
Gross
$17,205
32073
$11,885
IRINOTECAN LIPOSOMAL 4.3 MG/ML IV DISP
Gross
$16,978
8690
$11,762
LANREOTIDE 60 MG/0.2 ML SUBQ SYRG
Gross
$16,803
75000072
$11,742
HC UNLISTED PROCEDURE SMALL INTESTINE
Gross
$16,774
36100853
$11,316
HC SPLIT-THICKNESS AUTOGRAFT TRUNK/ARMS/LEGS FIRST 100 SQ CM OR LESS OR 1% OF BODY AREA OF INFANTS/C
Gross
$16,166
46561
$11,157
PEMIVIBART 125 MG/ML IV SOLN
Gross
$15,939
75000125
$10,572
HC ESOPH FLEX TRANSORAL W/ABLATION TUMOR/POLYP/OTHER LESIONS
Gross
$15,103
36000038
$10,494
HC OR ACUITY 4
Gross
$14,991
34738
$10,435
AVELUMAB 20 MG/ML IV SOLN
Gross
$14,907
42347
$10,353
RAMUCIRUMAB 10 MG/ML IV SOLN
Gross
$14,790
35333
$10,338
BENRALIZUMAB 30 MG/ML SUBQ ATIN
Gross
$14,769
41102
$10,132
NIVOLUMAB 240 MG/24 ML IV SOLN
Gross
$14,474
8692
$9,943
LUPRON 3.75MG IM KIT
Gross
$14,204
Showing top 50 of 14,184 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.